According to expert presenters at the American Society of Preventive Cardiology’s 2025 Congress on Cardiovascular Disease Prevention, recent studies have shown significant benefit to GLP-1 inhibitors ...

Most employees said health plans should cover GLP-1 medications, with 64% saying they should and 12% saying they should not.

ABC News medical correspondent Dr. Darien Sutton talks about GLP-1 drugs and access for teens and young adults in the U.S.

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.

Kylie was excited - her life was about to change. The school principal was three months from undergoing a gastric sleeve, ...

As excitement builds around GLP-1s and their expanding list of potential indications, the conversation is shifting from hype ...

Now, it’s worth noting Stock Advisor’s total average return is 1,019% — a market-crushing outperformance compared to 178 % ...

Scientists discovered that diabetes medicines like Ozempic, which help people lose weight, might also protect people's brains from strokes.

Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...

This study found that nearly 17 million adolescents and young adults were eligible for glucagon-like peptide-1 receptor agonist ...

Three new studies suggest that Ozempic and related diabetes and weight loss drugs may help protect the brain from strokes.